Antimicrobial Resistance (AMR)
Antimicrobial Resistance (AMR) – EP report – EU-wide plan to tackle the proliferation of AMR
Antimicrobial resistance (AMR) has been described as one of the biggest threats to public health – a worrisome development since resistance to drugs designed to treat severe diseases is becoming more widespread. In 2001 the WHO published its Global Strategy for Containment of Antimicrobial Resistance, describing what AMR is and what strategies should be implemented to control the escalation of the problem.
Whilst AMR has been recognised as a problem of increasing scale, until recently there was relatively little action to counter it. The Council adopted a set of conclusions calling upon the Commission to promote cooperation, followed by a further set of conclusions encouraging innovative incentives for effective antibiotics. In January 2012 the Council of the European Union issued a Recommendation on the prudent use of antimicrobial agents in human medicine. The European Parliament is to adopt its own initiative report on AMR in December 2012.
EPHA Policy Tracker Article (updated on 7 November 2013)
I. Background
II. Tracking the legislative procedure (past, present, future)
III. Contact Data of relevant Actors (MEPs, assistants, experts, attachés, industry, NGOs)
V. MEP questions and COM answers
(FULL UPDATE) Antimicrobial Resistance (AMR) – EP report – EU-wide plan to tackle the proliferation of AMR
————
EPHA Policy Tracker is a new intelligence feed produced by EPHA Secretariat to report developments to public health policy.
– You can find the list of all EPHA Policy Tracker articles here
————————
